FDA Investigator Jacquelyn Bradford
Jacquelyn Bradford has conducted inspections on 61 sites in 1 countries as of 05 Jun 2024. See below for a list of the FDA enforcement documents resulting from those inspections.
Investigator Details
Number of Inspected Sites:
61
Last Inspection Date:
05 Jun 2024
Investigator Role:
FDA Investigator
Redica ID:
Countries of Inspections:
United States of America
FDA Investigators that have inspected at least one site in common with Jacquelyn Bradford:
Alexis O Robinson,
Alissa C Rice,
Andrew Saunders,
Anetra E Wyatt,
Anthony D Peterson,
Ashley D Abraham,
Belinda A Walters,
C Tyfrans Francis,
Carl A Huffman, III,
Casey L Hamblin,
Charvais S Bogan,
Charvais S Hill,
Cherie T Parker,
Cheryl G Scott,
Christopher J Adams,
Christopher N Dedeaux,
Claire M Minden,
Clendening,
Clifton C Francis,
Combs,
Cynthia L Medlin,
Cynthia R Gibson,
David J Leray,
David R Heiar,
Debra A Taylor,
Decima L Washington,
Denise J Taylor,
Emily E Smith,
Erica L Sullivan,
Frank Flores,
Gloria J Horner,
Grant D Jones,
Heath W Cartwright,
Herbert M Corbello,
Holly I Hall,
James W Blakely,
Jason D Abel,
Jean A Peeples,
Jeffrey R Alling,
John M Mcinnis,
Johnathan M Crayton,
Joseph B Carballa,
Justin N Henson,
Karen R Smallwood,
Kate E Jesse,
Katherine A Indingaro,
Kimberly D Tucker,
Kimberly L Mcmillan,
Konsuela Y Glass,
Krista W Whitten,
Lacey J Chessor,
Lakisha N Morton,
Larry A Estavan,
Lawrence A Butler,
Linda A Gregory Duty,
Lindsay H Bertling,
Llopis,
Mahaffey,
Marcus L Head,
Margaret E Slimbach,
Marissa R Stough,
Markeesa M Scales,
Marshall H Kinsey,
Matthew B Thomaston,
Mcmillan,
Melanie L Drayton,
Nicole D Lyons,
Patrick C Dooley,
Peggy A Stogner,
Randy N Boling,
Robert E Hultman,
Samuel L Collins,
Sandy L Atkins,
Scott A Watson,
Shannon Atlas,
Shelton L Stribling,
Shirhonda D Thorn,
Shondra N Gipson,
Sidney M Smith,
Steven D Dittert,
Thomas B Smith,
Thomas O Morgan,
Thomas R Stanley,
Travis E Chapman,
Wayne S Fortenberry,
Zachary J Conlin,
Zada L Giles
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](https://redica.com/document-store/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more